Skip to main content

Advancements in pediatric vaccinology

Guest Editors

Rebecca F. Grais, PhD, HDR, Pasteur Network, France
Thanyawee Puthanakit, MD, MHS, Chulalongkorn University, Thailand

BMC Pediatrics called for submissions to our Collection on Advancements in pediatric vaccinology.
We invited submissions that study various aspects of pediatric vaccinology, from the development of novel vaccines to the assessment of safety profiles and exploration of factors influencing vaccine acceptance and coverage. Ensuring access to vaccines for all children worldwide is a critical component of reducing inequalities. Unfortunately, disparities persist in vaccine coverage, leaving vulnerable populations at higher risk of preventable diseases.

New Content ItemThis Collection supports and amplifies research related to SDG 10: Reduced Inequalities.

Meet the Guest Editors

Back to top

Rebecca F. Grais, PhD, HDR, Pasteur Network, France

Dr Rebecca F. Grais is the Executive Director of the Pasteur Network. She previously worked as the Director of Research at Epicentre, an epidemiology and research satellite created by Médecins Sans Frontières. Her primary areas of interest focus on prevention of infectious diseases and emerging infections in conflict contexts. An additional area concerns professional development, mentoring and management training for underrepresented populations to advance their careers and contribute to adapted healthcare innovations. She has published over 200 peer-reviewed publications, is a member of diverse scientific, funding and international organization committees and advisory groups and as member of SAGE.

Thanyawee Puthanakit, MD, MHS, Chulalongkorn University, Thailand

Dr Thanyawee Puthanakit is a Professor at Division of Pediatrics Infectious Diseases at Faculty of Medicine and a director of Center of Excellence in Pediatric Infectious Diseases and Vaccines at Chulalongkorn University. She was trained in Vaccine Science and Policy from Johns Hopkins Bloomberg School of Public Health in 2002, and Advanced Vaccinology Course in 2023. She has conducted several clinical vaccine trials such as 2-dose Human papilloma virus vaccine in adolescent girls, Japanese encephalitis B, pneumococcal conjugate vaccines in infants, pertussis vaccine as maternal immunization. During COVID19 pandemic, she conducted several studies in COVID vaccines in children and adolescents. She served as Thai Food and Drug administration expert committee for vaccines registration.

About the Collection

BMC Pediatrics welcomed for submissions to our Collection on Advancements in pediatric vaccinology.

Pediatric vaccines play a pivotal role in safeguarding children from preventable diseases, contributing to improved global health outcomes. The landscape of infectious diseases is continuously changing due to myriad factors. The COVID-19 pandemic greatly disrupted standard immunization uptake; the World Health Organization (WHO) stated that in 2022, 22 million children missed the first dosage of routine measles vaccination. By fostering collaboration and knowledge exchange, this Collection seeks to drive progress in pediatric vaccination, ensuring that children worldwide have access to the most effective and safest immunization interventions.

We invited submissions that study various aspects of pediatric vaccinology, from the development of novel vaccines to the assessment of safety profiles and exploration of factors influencing vaccine acceptance and coverage. The topics of interest include but are not limited to:

  • Novel vaccine development for pediatric populations
  • Innovative strategies for vaccine delivery, administration, and vaccination schedules in pediatric healthcare
  • Vaccines for emerging infectious diseases affecting children
  • Vaccine safety and efficacy, including real-world effectiveness
  • Immunization in special pediatric populations, including premature infants and those with underlying health conditions
  • Vaccination programs on a global scale, identifying challenges and successes


Ensuring access to vaccines for all children worldwide is a critical component of reducing inequalities. Unfortunately, disparities persist in vaccine coverage, leaving vulnerable populations at higher risk of preventable diseases. This Collection supports and amplifies research related to SDG 10: Reduced Inequalities.

Image credit: © Pixel-Shot / stock.adobe.com

  1. Routine childhood vaccination (RCV) has demonstrated its effectiveness, saving millions of lives globally and reducing childhood mortality. However, several factors impede mothers from completing their childre...

    Authors: Samuel Sem, Jacob Owusu Sarfo, Mustapha Amoadu and Thomas Hormenu
    Citation: BMC Pediatrics 2025 25:198